Biohaven Ltd.
BHVN
$30.40
-$0.57-1.84%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 18.84% | 36.80% | 30.52% | 90.41% | -75.25% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.47% | 61.17% | 255.04% | 135.58% | 40.16% |
| Operating Income | -16.47% | -61.17% | -255.04% | -135.58% | -40.16% |
| Income Before Tax | -27.97% | -51.48% | -262.48% | -157.26% | 32.19% |
| Income Tax Expenses | 103.96% | 98.21% | -91.87% | -39.40% | 91.43% |
| Earnings from Continuing Operations | -29.07% | -56.28% | -253.94% | -154.64% | 28.02% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -29.07% | -56.28% | -253.94% | -154.64% | 28.02% |
| EBIT | -16.47% | -61.17% | -255.04% | -135.58% | -40.16% |
| EBITDA | -16.30% | -61.61% | -259.97% | -138.78% | -38.87% |
| EPS Basic | -2.09% | -13.13% | -175.22% | -112.85% | 45.37% |
| Normalized Basic EPS | 5.02% | -9.62% | -173.86% | -107.94% | -9.96% |
| EPS Diluted | -2.09% | -13.13% | -175.22% | -112.85% | 45.37% |
| Normalized Diluted EPS | 5.02% | -9.62% | -173.86% | -107.94% | -9.96% |
| Average Basic Shares Outstanding | 26.43% | 38.13% | 28.60% | 19.64% | 31.76% |
| Average Diluted Shares Outstanding | 26.43% | 38.13% | 28.60% | 19.64% | 31.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
